Reaction: Olsalazine to 1 product
- Reaction
- Reaction type
- cleavage
- Direction
- Major circulating metabolite?
- Yes
- Spontaneous?
- No
- Activity
- active
- References
- Wadworth AN, Fitton A: Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease. Drugs. 1991 Apr;41(4):647-64. doi: 10.2165/00003495-199141040-00009. [Article]
- FDA Approved Drug Products: DIPENTUM (olsalazine) Oral Capsules (November 2022) [Link]
- Comments
- Not Available
- Enzymes
- Not Available